Pennsylvania researchers have discovered that a sizable percentage of patients potentially at risk for cancer would turn down testing to uncover genes linked to the disease. While their study named cost as the most likely reason, a number of other factors could influence individuals to nix the tests.
View the original article here: Patients Nix Genetic Tests Due to Cost: Study